Updates are available Correction dated 2022-12-15
Click to view Correction: https://doi.org/10.1038/s41568-022-00542-6
-
Authors
Casasent, Anna K.
Almekinders, Mathilde M. http://orcid.org/0000-0002-1554-2887
Mulder, Charlotta http://orcid.org/0000-0002-4886-8760
Bhattacharjee, Proteeti
Collyar, Deborah http://orcid.org/0000-0003-0886-0964
Thompson, Alastair M.
Jonkers, Jos http://orcid.org/0000-0002-9264-9792
Lips, Esther H. http://orcid.org/0000-0003-3488-4935
van Rheenen, Jacco http://orcid.org/0000-0001-8175-1647
Hwang, E. Shelley
Nik-Zainal, Serena
Navin, Nicholas E. http://orcid.org/0000-0002-2106-8624
Wesseling, Jelle http://orcid.org/0000-0002-8940-2676
,
Sawyer, Elinor J.
Davies, Helen R.
Futreal, Andrew
Navin, Nicholas E.
Hwang, E. Shelley
van Rheenen, Jacco
Behbod, Fariba
Schmidt, Marjanka
Wessels, Lodewyk F. A.
Rea, Daniel
Stobart, Hilary
Pinto, Donna
Verschuur, Ellen
van Oirsouw, Marja
- License Information
-
More Information
Article History
Accepted: 7 September 2022
First Online: 19 October 2022
Change Date: 15 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41568-022-00542-6
Competing interests
: S.N.Z. has filed the following patents on the use of mutational signatures for clinical applications: PCT/EP2017/06029, PCT/EP2017/060289, PCT/EP2017/060279, PCT/EP2017/060298 and PCT/EP2017/084409. The other authors declare no competing interests.
